Literature DB >> 16632304

Treatment of drug resistance in epilepsy: one step at a time.

Sanjay M Sisodiya, Susan E Bates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16632304     DOI： 10.1016/S1474-4422(06)70422-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  4 in total

Review 1.  PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.

Authors:  Severin Mairinger; Thomas Erker; Markus Muller; Oliver Langer
Journal:  Curr Drug Metab       Date:  2011-10       Impact factor: 3.731

2.  A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET.

Authors:  Claudia C Wagner; Martin Bauer; Rudolf Karch; Thomas Feurstein; Stephan Kopp; Peter Chiba; Kurt Kletter; Wolfgang Löscher; Markus Müller; Markus Zeitlinger; Oliver Langer
Journal:  J Nucl Med       Date:  2009-11-12       Impact factor: 10.057

3.  Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients.

Authors:  Aiman Abrahim; Gert Luurtsema; Martin Bauer; Rudolf Karch; Mark Lubberink; Ekaterina Pataraia; Christian Joukhadar; Kurt Kletter; Adriaan A Lammertsma; Christoph Baumgartner; Markus Müller; Oliver Langer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-11       Impact factor: 9.236

4.  A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil.

Authors:  Claudia C Wagner; Marie Simpson; Markus Zeitlinger; Martin Bauer; Rudolf Karch; Aiman Abrahim; Thomas Feurstein; Matthias Schütz; Kurt Kletter; Markus Müller; Graham Lappin; Oliver Langer
Journal:  Clin Pharmacokinet       Date:  2011-02       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.